Evaxion A (EVAX) Receivables (2019 - 2025)
Evaxion A (EVAX) posted Receivables of $424000.0 for Q2 2025, up 552.31% on a QoQ basis from $65000.0 in Q4 2024, and up 8.16% year-over-year from $392000.0 in Q2 2024.
Evaxion A (EVAX) Receivables (2019 - 2025) Analysis & Trends
Evaxion A's Receivables history runs 7 years deep, the most recent figure standing at $424000.0 for Q2 2025.
- Quarterly Receivables rose 8.16% year-over-year to $424000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $424000.0 (up 8.16% YoY) and the FY2024 annual result came in at $65000.0, down 96.84% from the prior year.
- Receivables was $424000.0 for Q2 2025 at Evaxion A, up from $65000.0 in the prior quarter.
- Across five years, Receivables topped out at $2.8 million in Q4 2022 and bottomed at $65000.0 in Q4 2024.
- A 5-year average of $666272.7 and a median of $424000.0 in 2025 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables surged 123.9% — and 2023, when it sank 96.14%.
- Evaxion A's Receivables stood at $1.3 million in 2021, then jumped by 123.9% to $2.8 million in 2022, then sank by 96.14% to $108000.0 in 2023, then tumbled by 39.81% to $65000.0 in 2024, then surged by 552.31% to $424000.0 in 2025.
- Business Quant data shows EVAX's Receivables at $424000.0 in Q2 2025, $65000.0 in Q4 2024, and $392000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 424,000.00 |
| Dec 31, 2024 | 65,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Jun 30, 2023 | 425,000.00 |
| Dec 31, 2022 | 2.80 Mn |
| Jun 30, 2022 | 401,000.00 |
| Mar 31, 2022 | 245,000.00 |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 668,000.00 |
| Jun 30, 2021 | 549,000.00 |
| Dec 31, 2020 | 1.56 Mn |
| Dec 31, 2019 | 607,000.00 |